Joseph O. Moore

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

Krzysztof Mrózek, Guido Marcucci, Deedra Nicolet et al. · Journal of Clinical Oncology · 2012 · 405 citations · Full text

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert et al. · Journal of Clinical Oncology · 2005 · 381 citations

<i>TET2</i> Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Klaus H. Metzeler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2011 · 319 citations · Full text

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

Klaus H. Metzeler, Heiko Becker, Kati Maharry et al. · Blood · 2011 · 274 citations · Full text

<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

Jason H. Mendler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2012 · 265 citations